The Telegram - News - Canada - World - Business

Article

Print
Send to a friend
Comment (0)

Swiss drugmaker Roche posts 7 per cent profit rise, helped by sale of cancer drugs

Published on July 26, 2012; Published on July 26, 2012

Topics :: Roche Holding AG , GENEVA , Basel , Zurich

GENEVA - Swiss drug maker Roche Holding AG has reported a 7 per cent rise in core operating profit to 8.6 billion Swiss francs in the first half, helped by sales of cancer drugs and recent cost-cutting.

The Basel, Switzerland-based company's half-year results also show that excluding the effect of the strong Swiss currency its group sales rose 4 per cent to 22.4 billion francs.

The company's results issued Thursday before the opening of the Zurich exchange said that its net income fell 14 per cent mainly due to one-off costs from the closure of its Nutley, New Jersey, site.

The former U.S. headquarters is to be closed by the end of 2013 in a money-saving consolidation of research and development programs.

Roche also confirmed its full-year outlook for sales in low to middle single-digit rates.

©

Rate
Top of the page

Submit a comment

Submit a comment Your name* Email* (we keep all emails private) Write your comment here*

Agreement

We ask that users remain courteous. You may not post insulting, discriminatory or inappropriate content, which may be removed at our discretion. We are not responsible for user content and opinions. Use of this site as well as content submission & ownership are governed by our Conditions of Use and Privacy Policy.

Member organizations should be non-profit in nature, and promote legal activities. Any organization found promoting illegal activities or commercial products or services will be deleted from the site.

I agree with these conditions.